Skip to main navigation Skip to search Skip to main content

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues

  • Aristeidis Lentzas
  • , Anna Their
  • , Jos H. Beijnen
  • , Mark C. de Gooijer
  • , Olaf van Tellingen
  • Netherlands Cancer Institute
  • University of Manchester
  • The Christie NHS Foundation Trust

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

A rapid and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for quantifying ABT-751, an anticancer agent targeting microtubules. Sample preparation involved protein precipitation using acetonitrile and formic acid (100:1, v/v), providing efficient ABT-751 extraction with minimal ion suppression. Buparlisib (BKM-120) served as the internal standard. Chromatographic separation was achieved on a Zorbax Extend C18 column, with gradient elution from 20 to 95% methanol in 0.1% (v/v) formic acid in water, and MS/MS detection was performed in positive ionization mode. This assay was validated for human plasma, mouse plasma, and various mouse tissues, including brain, liver, lung, and kidney homogenates. Calibrants were prepared in each respective blank biological matrix, except for mouse tumor tissue, and curves were fitted by quadratic regression from 5 to 10,000 nM. For mouse tumor tissue we used human plasma as surrogate matrix for calibrants. Precision and accuracy for intra-day and inter-day measurements were within acceptable limits across low, medium, and high concentrations for all matrices. Stability concerns with ABT-751 in mouse plasma and tissue homogenate samples that were stored for more than 8 months were identified and addressed. A pilot pharmacokinetic study in mice demonstrated the applicability of this validated LC-MS/MS method.
Original languageEnglish
Article numbere70099
Pages (from-to)1-13
Number of pages13
JournalBiomedical Chromatography
Volume39
Issue number6
DOIs
Publication statusPublished - Jun 2025

Bibliographical note

Publisher Copyright:
© 2025 John Wiley & Sons Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ABT-751 quantitation
  • LC-MS/MS method validation
  • Mouse plasma
  • Protein precipitation
  • Stability
  • Tissue homogenates

Fingerprint

Dive into the research topics of 'Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues'. Together they form a unique fingerprint.

Cite this